Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples